Best Form of Ginkgo Biloba: How to Choose

Best Form of Ginkgo Biloba: How to Choose

Ginkgo biloba is one of the few botanical supplements that has been tested as rigorously as a medicine. That also means almost everything credible about it comes from one very specific thing: a standardised leaf extract. Two jars that both say "Ginkgo biloba 120 mg" can contain completely different products. One holds an extract whose flavone glycoside and terpene lactone content has been measured in a laboratory and fixed; the other holds ground dried leaf, with an active content many times lower and varying from batch to batch.

This guide walks through every form you will actually find on the Estonian market, what the research says about each one, what a day of use really costs, and who should not take ginkgo at all. Prices come from the MaxFit range at the time of writing and change over time.

Why "standardised" is the only word on the label that matters

Ginkgo leaf contains two groups of actives that matter in clinical trials: flavone glycosides (derivatives of quercetin, kaempferol and isorhamnetin) and terpene lactones (ginkgolides A, B, C and bilobalide). Essentially all of the serious research literature used extracts containing roughly 24% flavone glycosides and 6% terpene lactones. The most studied of these is the German extract EGb 761 (Ihl et al., 2011).

Why that ratio matters: raw ginkgo leaf typically contains only a few percent flavone glycosides by dry weight. Reaching extract concentration takes on the order of fifty kilos of leaf per kilo of extract. So 120 mg of standardised extract is not the same thing as 120 mg of leaf powder — the difference is orders of magnitude, not percentages.

Standardisation controls a second thing as well. Raw ginkgo leaf contains ginkgolic acids, known contact allergens, whose content in a quality extract is usually limited to below 5 ppm. In leaf powder and home-brewed leaf tea nobody checks that limit, because nobody measures.

The practical rule in front of a shelf: if the label states neither a percentage of flavone glycosides nor an extract ratio (for example 50:1), you are probably not holding the product the trials used. Estonian shops still sell products whose ingredient line simply reads "Ginkgo biloba leaf 400 mg" with no standardisation claim at all — and on the shelf they look exactly as confident as the proper extracts.

The forms you will actually see in Estonia

Standardised extract capsules. The most common form and in practice the only one you can cite research for. Typically 60-120 mg of extract per capsule with 24/6 standardisation. In the MaxFit range this is MST Ginkgo Biloba 60caps, 16.90 EUR per jar at the time of writing. Capsules are also the easiest format for splitting the daily dose, which ginkgo genuinely benefits from — more on that below.

Tablets. Essentially the same material pressed together. The advantage is price in larger packs; the drawback is more binder and a less predictable disintegration time in the stomach. If your stomach is sensitive, capsules are the safer pick.

Leaf powder and encapsulated leaf powder. Cheap, and mostly pointless. To reach the same active dose you would have to take several grams at once, and even then the terpene lactone content would be unknown. If the ingredient line reads "Ginkgo biloba folium, powder" with no extract ratio, you are paying for plant flour.

Liquid extracts and tinctures. Alcohol- or glycerine-based extracts. In theory faster absorption; in practice dropper accuracy is poor and the price per milligram is high. Alcohol-based tinctures are also unsuitable for anyone avoiding alcohol entirely.

Leaf tea. A pleasant drink, but pharmacologically it is usually a cup-of-coffee-level event. Hot water extracts some of the flavonoids, but terpene lactones dissolve poorly in water. Drinking tea, you never know how much you actually got.

Combination "brain" formulas. Ginkgo alongside B vitamins, L-theanine or bacopa. The problem is almost always the dose: 40 mg of ginkgo in a multi-ingredient capsule is a label dose, not a working dose. If you intend to test ginkgo, test it alone, or in three months you will not know what did or did not work. The same logic applies to any single ingredient, whether a plant extract or an amino acid.

Form comparison

What the research actually shows — and what it does not

Here is the honest part most supplement pages quietly skip. The large, long, well-conducted ginkgo trials have not shown that it prevents dementia or cognitive decline in a healthy ageing person.

The GEM study followed more than three thousand older participants for close to six years on 120 mg twice daily, and found no reduction in dementia incidence (DeKosky et al., 2008). A follow-up analysis of the same cohort found no slowing of decline on cognitive tests either (Snitz et al., 2009). The European GuidAge trial, in which 2,854 older adults with memory complaints took EGb 761 for five years, reached the same conclusion for Alzheimer's disease (Vellas et al., 2012).

A different picture emerges once someone already has a diagnosed cognitive impairment. A Cochrane review noted that results are inconsistent but described some cognitive benefit at doses above 120 mg (Birks & Grimley Evans, 2009), and a later randomised trial at 240 mg per day showed improvement in dementia patients with neuropsychiatric symptoms (Ihl et al., 2011). That is a clinical population and a clinical decision, not a matter of self-diagnosis, and the distinction matters.

An honest summary for a healthy person: ginkgo is neither a dramatic nootropic nor a preventive medicine. If you try it, try it for subjective clarity and peripheral circulation, knowing that the well-controlled result is modest. That is also exactly why the choice of form matters: when the expected effect is small, an under-dosed leaf powder guarantees zero.

It is worth noting what those trials did not measure. Most of the large studies looked at older adults and dementia risk, not at a thirty-year-old trying to plug an afternoon attention gap. There simply is not a comparable body of data there, and any manufacturer promising a healthy young adult a measurable cognitive boost is going further than the literature supports. The same applies to circulation: ginkgo has shown effects on peripheral blood flow measures in trials, but that is not a promise that cold fingers in January will disappear.

How to check quality from the label

Four things worth looking at while you turn the jar around, all doable in thirty seconds:

1. Extract ratio or percentage. 24% flavone glycosides and 6% terpene lactones, or at least a ratio such as 50:1. If it is absent, the rest of the text does not matter.
2. Dose per capsule, not "per serving". Some manufacturers state the dose across three capsules, which makes the jar last a third as long as it first appears.
3. A ginkgolic acid limit. A good manufacturer prints "< 5 ppm ginkgolic acids". The presence of that line is itself a quality signal, because it means somebody measured.
4. Packaging size and transparency. The extract is sensitive to light and moisture. A big clear jar sitting in a cupboard for six months is not a good deal, even if the price per capsule is lower.

Dose, timing and duration

The range used in trials is 120-240 mg of standardised extract per day. Doses below 120 mg are largely ineffective in the literature; above 240 mg adds no further benefit but does add gastrointestinal complaints.

Two things product labels rarely tell you:

First, split dosing is more common in the literature than one large dose. The half-life of terpene lactones is on the order of a few hours, so 60 mg in the morning and 60 mg around lunch keeps levels steadier than 120 mg at once.

Second, ginkgo is not a "feel it in an hour" supplement. Clinical protocols produce results over weeks, not hours, and a trial shorter than eight weeks tells you nothing. If you plan to test it, plan two to three consecutive months, then judge honestly whether anything changed. The finer points of timing are covered separately in when to take Ginkgo biloba.

The safety of long-term use has its own article, is long-term Ginkgo biloba use safe, because it is the single most common question our customer support receives.

Price: what one day really costs

With supplements, the jar price is misleading. Always calculate the daily cost.

Take MST Ginkgo Biloba 60caps at 16.90 EUR at the time of writing. If a capsule delivers 60 mg of standardised extract and you take two per day (120 mg total), the jar lasts 30 days and a day costs roughly 0.56 EUR. Take one capsule a day and the day costs 0.28 EUR — but you are also below the trial dose, and this is the typical way people spend months paying for a supplement that cannot work at that dose.

For comparison, ginkgo in an Estonian pharmacy is typically in a higher price bracket, partly because some products are registered as herbal medicines with the documentation burden that entails. The medicinal form has the advantage of tighter content control. The food-supplement form has the advantage of price and range. Neither is automatically better — look at the standardisation, not at which shelf the product sits on.

A third cost people ignore is the interrupted course. Buy a jar, take it for three weeks, forget about it, restart two months later, and you have paid full price for clinically nothing, because no protocol produces a result in three weeks. With ginkgo, consistency is literally money: a broken course is more expensive than a continuous one even though the same number of jars gets used. If you know the morning capsule quietly gets skipped, put the jar where your morning already stops.

Who should skip ginkgo

This list is longer than usual, and it is a core part of the article rather than an afterthought.

• Anyone on blood thinners. Ginkgolide B affects platelet activation. A large systematic review found no meaningful bleeding risk from standardised extract in healthy people (Kellermann & Kloft, 2011), but combined with warfarin, clopidogrel or regular aspirin this is a doctor's decision, not a shop's.
• Before surgery. The usual advice is to stop at least two weeks before planned surgery or a dental implant.
• People with epilepsy. The ginkgotoxin in raw leaf and poorly purified extracts is a genuine concern regarding seizure threshold.
• Pregnancy and breastfeeding. Data are lacking, so no.
• Under-18s. Same reason.
• Anyone already stacking several herbal blends. We cover ginkgo's interactions in more depth in Ginkgo biloba interactions.

If you are on this list, choosing a better form fixes nothing. Form is a question only once ginkgo itself is appropriate for you.

A practical protocol if you decide to try it

1. Choose a standardised extract at 24% / 6%. If that number is not on the label, put it back.
2. Start at 120 mg per day, split into two doses, taken with food.
3. Keep the same product and the same dose for at least eight weeks.
4. Write down two concrete things you expect to change — for example afternoon focus duration, or how sensitive your hands are to cold in winter. A general "feel better" is not measurable.
5. Decide at eight weeks. If nothing changed, stop — this is not a product where "another six months" is a good plan.
6. If you take other medication, talk to a pharmacist first, not afterwards.

Where ginkgo sits in the rest of the basket

Most people who buy ginkgo buy it for cognitive clarity. It is worth saying plainly that the basics of sleep, training and protein intake do more than any plant extract. If your daily protein is below 1.2 grams per kilogram of body weight, fixing that is a far bigger lever than fine-tuning a ginkgo dose.

In practice that means sorting the base out before optimising botanical extracts. A simple protein top-up such as MST Protein Best Whey + Enzymes 510g Küpsised ja kreem (25.90 EUR at the time of writing) or Optimum-nutrition Gold Standard 100% Whey 450g Vanillijäätis (24.90 EUR) fills the daily protein gap more cheaply than most nootropic formulas. The full protein range sits under proteins, and ginkgo products under ginkgo biloba.

If you are after general coverage rather than one targeted compound, vitamin complexes are a more sensible first purchase than any single plant extract. In an Estonian winter most people's vitamin D status is lower than in summer anyway, and that is a far better documented problem than scattered attention.

FAQ

Does ginkgo leaf tea work the same way as a capsule?

No. Tea extracts some flavonoids, but terpene lactones dissolve poorly in water and the final dose is unknown. Drink the tea as a drink, but do not transfer trial results to it.

How long before I feel anything?

Clinical protocols measure results in weeks. Plan at least eight weeks before judging, and do not expect an hour-scale effect.

Is a higher dose better?

Up to 240 mg per day is the range used in the literature. Above that there is no proven additional benefit, but there are more gastrointestinal complaints and headaches.

Can I take ginkgo with coffee?

Yes, there is no direct contraindication. But if you are testing ginkgo for cognitive clarity, keep your caffeine intake stable during the trial, or you will not know which one did anything.

When should I give up completely?

If eight to twelve consecutive weeks at the correct dose produce no measurable change, you do not need a third month. A supplement that does not work does not start working better with time.

Does the extract need to be cycled?

In clinical trials ginkgo has been given continuously for months and years, so you do not need to build in breaks. It is worth reviewing every couple of months whether you are getting what you pay for.

References

Birks, J., & Grimley Evans, J. (2009). Ginkgo biloba for cognitive impairment and dementia. Cochrane Database of Systematic Reviews, (1), CD003120.

DeKosky, S. T., Williamson, J. D., Fitzpatrick, A. L., et al. (2008). Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA, 300(19), 2253-2262. https://pubmed.ncbi.nlm.nih.gov/19017911/

Ihl, R., Bachinskaya, N., Korczyn, A. D., et al. (2011). Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial. International Journal of Geriatric Psychiatry, 26(11), 1186-1194. https://pubmed.ncbi.nlm.nih.gov/21140383/

Kellermann, A. J., & Kloft, C. (2011). Is there a risk of bleeding associated with standardized Ginkgo biloba extract therapy? A systematic review and meta-analysis. Pharmacotherapy, 31(5), 490-502. https://pubmed.ncbi.nlm.nih.gov/21923430/

Snitz, B. E., O'Meara, E. S., Carlson, M. C., et al. (2009). Ginkgo biloba for preventing cognitive decline in older adults: a randomized trial. JAMA, 302(24), 2663-2670. https://pubmed.ncbi.nlm.nih.gov/20040554/

Vellas, B., Coley, N., Ousset, P. J., et al. (2012). Long-term use of standardised Ginkgo biloba extract for the prevention of Alzheimer's disease (GuidAge): a randomised placebo-controlled trial. The Lancet Neurology, 11(10), 851-859. https://pubmed.ncbi.nlm.nih.gov/22959217/